| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +5M | 100% | $1.00 | +$5M |
| Sells | 0 | ||||
| Net | +1 | +5M | 100% | +$5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10%+ Owner | $4.49M | +$5M | 08 Oct 2025 | |
| CARL L. GORDON | Director, 10%+ Owner | $942K | 21 Aug 2024 | ||
| Francesco Galimi | SVP & Chief Medical Officer | $244K | 05 Jun 2024 | ||
| Aya Jakobovits | Director | $214K | 21 Aug 2024 | ||
| Chen Schor | President & CEO, Director | $176K | 31 Jan 2025 | ||
| Brian Nicholas Harvey | Chief Financial Officer | $83.9K | 31 Jan 2025 | ||
| Lloyd Klickstein | Director | $66.2K | 11 Jun 2025 | ||
| Don Healey | Chief Technology Officer | $58.8K | 31 Jan 2025 | ||
| Blake Aftab | Chief Scientific Officer | $51.8K | 31 Jan 2025 | ||
| STEVE DUBIN | Director | $13.8K | 11 Jun 2025 | ||
| Andrew Sinclair | Director | $10.8K | 11 Jun 2025 | ||
| Jeffrey Chodakewitz | Director | $10.8K | 11 Jun 2025 | ||
| Michael Kauffman | Director | $8.44K | 21 Aug 2024 | ||
| Katie Peng | Director | $7.2K | 11 Jun 2025 | ||
| Julia D. Maltzman | Chief Medical Officer | 31 Jan 2025 | |||
| Michael Grissinger | Director | 17 Apr 2025 | |||
| STEWART ABBOT | Former Chief Scientific and Operating Officer | 11 Jun 2021 | |||
| Bastiano Sanna | Director | 14 Aug 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|